This review describes the definition, incidence, clinical implications, and magnetic
resonance imaging (MRI) findings of pseudoprogression of brain tumors, in particular, but …

Despite the fact that MRI has evolved to become the standard method for diagnosis and
monitoring of patients with brain tumours, conventional MRI sequences have two key …

Despite the widespread clinical use of dynamic susceptibility contrast (DSC) MRI, DSC-MRI
methodology has not been standardized, hindering its utilization for response assessment in …

Glioblastoma (GBM) is a primary neuroepithelial tumor of the central nervous system,
characterized by an extremely aggressive clinical phenotype. Patients with GBM have a …

The use of radiotherapy, either in the form of stereotactic radiosurgery (SRS) or whole-brain
radiotherapy (WBRT), remains the cornerstone for the treatment of brain metastases (BM) …

Background MRI characteristics of brain gliomas have been used to predict clinical outcome
and molecular tumor characteristics. However, previously reported imaging biomarkers have …

Background Pseudoprogression is a diagnostic challenge in early posttreatment
glioblastoma. We therefore developed and validated a radiomics model using …

Advanced molecular and pathophysiologic characterization of primary central nervous
system lymphoma (PCNSL) has revealed insights into promising targeted therapeutic …

Objective Treatment response assessment in high-grade gliomas uses contrast enhanced
T1-weighted MRI, but is unreliable. Novel advanced MRI techniques have been studied, but …

The wide variety of treatment options that exist for glioblastoma, including surgery, ionizing
radiation, anti-neoplastic chemotherapies, anti-angiogenic therapies, and active or passive …